 |
Cisplatin-Based Chemo Improves Post-Op Survival in NSCLC
After complete resection of non-small cell lung cancer (NSCLC), there is a significant improvement in survival when cisplatin-based chemotherapy is administered, according to results of a meta-analysis involving more than 4,500 patients. more...
Stem Cells Could Allow ''Blood Farms,''
Embryonic stem cells can be used to grow vats of red blood cells, which could lead to the creation of "farms" that could provide limitless sources of blood, U.S. researchers reported on Tuesday. more...
Doxorubicin-Zoledronic Acid Sequence Effective Against Breast Cancer in Lab
Sequential treatment with doxorubicin followed by zoledronic acid is effective in a mouse model of breast cancer, according to a report in the August 20th issue of the Journal of the National Cancer Institute.
more...
Merck Vioxx Study Was For Marketing: Researchers Conclude
The primary purpose of a 1999 clinical study that Merck & Co Inc said was done to test side effects of Vioxx was actually to support a marketing campaign before the now-withdrawn painkiller's launch, according to U.S. researchers. more...
Crucial Genetic Factor in Colorectal Cancer Found
Researchers have identified what they see as the leading cause of inherited colorectal cancer -- a genetic abnormality that makes a person about nine times more likely to get the disease. more...
In Myelodysplastic Syndrome, Erythropoietin Improves Anemia With No Increase in Leukemia Risk
Treating the anemia associated with myelodysplastic syndrome using erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) may benefit patients who have little or no need for transfusions, according to a report by European researchers in the July 20 issue of the Journal of Clinical Oncology. more...
Delayed Axillary Node Dissection Not Detrimental in Breast CA Patients with Positive Sentinel Nodes
Delaying axillary node dissection for a few weeks does not appear to be detrimental in breast cancer patients with positive sentinel nodes, according to a report in the July 20th Journal of Clinical Oncology. more...
Perceived Bias Tied to Lower Cancer Screening Rates
Minority men and women who believe their health providers are biased against them are less likely to be screened for breast and colon cancers, a new study suggests.
more...
|
|
|
|
 |